References: A Brave New World: Therapeutic Area Deep Dives on Obesity This blog is part of a new series exploring a range of topics in the obesity market, including: market size and scope, impact of payer controls, activity in non-traditional channels, patient behavior, GLP-1 impact, HCP responses, the policy landscape, pharmacy economics, and the outlook for the future of GLP-1
multi-month plans re-rate to a shorter-term price if canceled early
SGLT2 inhibitors provide substantial benefits for people with type 2 diabetes mellitus and either established HF or elevated HF risk [86]
Retatrutide, as the newest and most advanced triple-agonist metabolic peptide, sits at the higher end of the research peptide pricing range but the gap between the cheapest Canadian retatrutide and the most expensive isn't arbitrary, and it's not always proportional to quality
If results were minimal, redirect resources to approaches with better evidence
To test the local effects of GLP-1(736) and exendin 939 on heat sensitivity, PWL was measured via the Hargreaves radiant heat apparatus following intraplantar administration of 10 g of GLP-1(736) or vehicle (0.9% saline) ( n = 5 per group) in a volume of 10 L
